BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nguyen JT, Tian DD, Tanna RS, Hadi DL, Bansal S, Calamia JC, Arian CM, Shireman LM, Molnár B, Horváth M, Kellogg JJ, Layton ME, White JR, Cech NB, Boyce RD, Unadkat JD, Thummel KE, Paine MF. Assessing Transporter-Mediated Natural Product-Drug Interactions Via In vitro-In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail. Clin Pharmacol Ther 2021;109:1342-52. [PMID: 33174626 DOI: 10.1002/cpt.2107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Bi Y, Wang X, Ding H, He F, Han L, Zhang Y. Transporter-mediated Natural Product-Drug Interactions. Planta Med 2023;89:119-33. [PMID: 35304735 DOI: 10.1055/a-1803-1744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Liu J, Banuvar S, Viana M, Barengolts E, Chen SN, Pauli GF, van Breemen RB. Pharmacokinetic Interactions of a Licorice Dietary Supplement with Cytochrome P450 Enzymes in Female Participants. Drug Metab Dispos 2023;51:199-204. [PMID: 36328482 DOI: 10.1124/dmd.122.001050] [Reference Citation Analysis]
3 Zhang J, Chen Y, Fan W, Li L, Ma Y, Wang Z, Shi R, Yang L. Study on herb-herb interaction between active components of Plantago asiatica L. seed and Coptis chinensis Franch. rhizoma based on transporters using UHPLC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis 2023. [DOI: 10.1016/j.jpba.2023.115234] [Reference Citation Analysis]
4 Haron MH, Dale O, Martin K, Avula B, Chittiboyina AG, Khan IA, Gurley BJ, Khan SI. Evaluation of the Herb-Drug Interaction Potential of Commonly Used Botanicals on the US Market with Regard to PXR- and AhR-Mediated Influences on CYP3A4 and CYP1A2. J Diet Suppl 2022;:1-14. [PMID: 36017806 DOI: 10.1080/19390211.2022.2110351] [Reference Citation Analysis]
5 Hassen G, Belete G, Carrera KG, Iriowen RO, Araya H, Alemu T, Solomon N, Bam DS, Nicola SM, Araya ME, Debele T, Zouetr M, Jain N. Clinical Implications of Herbal Supplements in Conventional Medical Practice: A US Perspective. Cureus 2022. [DOI: 10.7759/cureus.26893] [Reference Citation Analysis]
6 Brouwer KLR, Evers R, Hayden E, Hu S, Li CY, Meyer Zu Schwabedissen HE, Neuhoff S, Oswald S, Piquette-Miller M, Saran C, Sjöstedt N, Sprowl JA, Stahl SH, Yue W. Regulation of Drug Transport Proteins-From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium. Clin Pharmacol Ther 2022. [PMID: 35390174 DOI: 10.1002/cpt.2605] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
7 Adiwidjaja J, Boddy AV, Mclachlan AJ. Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib. Eur J Clin Pharmacol. [DOI: 10.1007/s00228-021-03266-y] [Reference Citation Analysis]
8 Liu Y, Yang F, Zhao X, Wang S, Yang Q, Zhang X. Crystal Structure, Solubility, and Pharmacokinetic Study on a Hesperetin Cocrystal with Piperine as Coformer. Pharmaceutics 2022;14:94. [PMID: 35056990 DOI: 10.3390/pharmaceutics14010094] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
9 Cox EJ, Rettie AE, Unadkat JD, Thummel KE, McCune JS, Paine MF. Adapting regulatory drug-drug interaction guidance to design clinical pharmacokinetic natural product-drug interaction studies: A NaPDI Center recommended approach. Clin Transl Sci 2021. [PMID: 34699676 DOI: 10.1111/cts.13172] [Reference Citation Analysis]